Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a)

European Journal of Endocrinology

Volumn 136, Issue 4, 1997, Pages 377-381

  Laron, Z ^a,c   Wang, X L ^b   Klinger, B ^a   Silbergeld, A ^a   Wilcken, D E L ^b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c SCHNEIDER CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FK 780; GROWTH HORMONE; HEXARELIN; HUMAN GROWTH HORMONE; LIPOPROTEIN A; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; INTRANASAL DRUG ADMINISTRATION; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; SHORT STATURE; SUBCUTANEOUS DRUG ADMINISTRATION; TURNER SYNDROME;

EID: 0030965262     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1360377     Document Type: Article

References (33)

1. Dahlen GH. Lp(a) lipoprotein in cardiovascular disease (Review). Atherosclerosis 1994 108 111-126.
2. Utermann G. The mysteries of lipoprotein(a) (Review). Science 1989 246 904-910.
3. Scanu AM & Fless GM. Lipoprotein(a). Heterogeneity and biological relevance (Review). Journal of Clinical Investigation 1990 85 1709-1715.
4. Lackner C, Boerwinkle E, Leffert CC, Rahmig T & Hobbs HH. Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulse-field gel electrophoresis. Journal of Clinical Investigation 1991 87 2077-2086.
5. Cohen JC, Chiesa G & Hobbs HH. Sequence polymorphisms in the apolipoprotein(a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels. Journal of Clinical Investigation 1993 91 1630-1636.
6. Boerwinkle E & Fornage M. Genetics of Lp(a) lipoprotein. An evolving paradigm. In Genetics of Coronary Heart Disease, pp 33-52. Ed AG Bearn. Oslo: Institute of Medical Genetics, University of Oslo, 1992.
7. Wang XL, Wilcken DEL & Dudman NPB. Early expression of apolipoprotein(a) gene: relationships between infants' and their parents' serum apolipoprotein(a) levels. Pediatrics 1992 89 401-406.
8. Wilcken DEL, Wang XL, Greenwood J & Lynch J. Lipoprotein(a), apolipoprotein B and AI in children and coronary events in their grandparents. Journal of Pediatrics 1993 123 519-526.
9. Black IW & Wilcken DEL. Decreases in apolipoprotein(a) after renal transplantation: implications for lipoprotein(a) metabolism. Clinical Chemistry 1992 38 353-357.
10. Parra HJ, Mezdour H, Cachera C, Dracon M, Tacquet A & Fruchart JC. Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis. Clinical Chemistry 1987 33 721.
11. Dullaart RP, van Doormaal JJ, Hoogenberg K & Sluiter WJ. Triiodothyronine rapidly lowers plasma lipoprotein(a) in hypothyroid subjects. Netherlands Journal of Medicine 1995 46 179-184.
12. Sacks FM, McPherson R & Walsh BW. Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations. Archives of Internal Medicine 1994 145 1106-1110.
13. Soma MR, Osnago-Gadda I, Paoletti R, Fumagalli R, Morriseff JD, Meschia M & Crosignani P. The lowering of lipoprotein(a) induced by estrogen plus progesterone replacement therapy in postmenopausal women. Archives of Internal Medicine 1993 153 1452-1468.
14. Shewmon DA, Stock JL, Rosen CJ, Heiniluoma KM, Hogue MM, Morrison A et al. Tamoxifen and estrogen lower circulating lipoprotein(a) concentrations in healthy postmenopausal women. Arteriosclerosis and Thrombosis 1994 14 1586-1593.
15. Jorgensen JOL, Moller N, Moller J, Laursen T & Christiansen JS. Deficient adults: effects of GH replacement therapy. In Growth Hormone Replacement Theraphy in Adults - Pros and Cons, pp 31-40. Eds Z Laron & O Butenandt. Tel Aviv, London: Freund Publishing House Ltd, 1993.
16. Laron Z, Wasserman M, Neuhaus H, Meyerovitch J & Silbergeld A. Retreatment of young adult GH deficient patients. In Growth Hormone Replacement Therapy in Adults - Pros and Cons, pp 99-114. Eds Z Laron Z & O Butenandt. Tel Aviv, London: Freund Publishing House Ltd, 1993.
17. Wang XL, Wilcken DEL & Dudman NPB. An indirect sandwich ELISA for serum and dried blood spot Lp(a) measurements, comparison to a commercial RIA. Clinica Chimica Acta 1992 207 73-86.
18. Laron Z, Klinger B, Silbergeld A, Lewin B, Erster B & Gil-Ad I. Intravenous administration of recombinant IGF-I lowers serum GHRH and TSH. Acta Endocrinologica 1990 123 378-382.
19. Caprio S, Boulware D & Tamborland V. Growth hormone and insulin interactions. Hormone Research 1992 38 (Suppl 2) 47-49.
20. Laron Z, Klinger B, Jensen LT & Erster B. Biochemical and hormonal changes induced by one week of administration of rIGF-I to patients with Laron type dwarfism. Clinical Endocrinology 1991 35 145-150.
21. Klinger B & Laron Z. Three year IGF-I treatment of children with Laron syndrome. Journal of Pediatric Endocrinology and Metabolism 1995 8 149-158.
22. Gafny M, Silbergeld A, Klinger B, Wasserman M & Laron Z. Comparative effects of GH, IGF-I and insulin on serum hormone binding globulin. Clinical Endocrinology 1994 41 169-175.
23. Sutherland WH, Lewis-Barned NJ, Pratt MC, Tillman HC & Walker RJ. The response of plasma lipoprotein(a) concentration to acute hyperinsulinemia in patients with non-insulin dependent diabetes and in healthy subjects. Research Communications in Chemical Pathology and Pharmacology 1994 83 77-86.
24. Kuusi T, Yki-Jarvinen H, Kauppinen-Makelin R, Jauhiainen M, Ehnholm C, Kauppila M et al. Effect of insulin treatment on serum lipoprotein(a) in non-insulin-dependent diabetes. European Journal of Clinical Investigation 1995 25 194-200.
25. Oscarsson J, Ottosson M, Wiklund O, Marin P, Vikman-Adolfsson K, Bjorntorp P & Eden S. Low dose continuously infused growth hormone results in increased lipoprotein(a) and decreased density lipoprotein cholesterol concentrations in middle-aged men. Clinical Endocrinology 1994 41 109-116.
26. Oscarsson J, Lundstam UK, Gustafsson B, Wilton P, Eden S & Wiklund O. Recombinant human insulin-like growth factor-I decreases serum lipoprotein(a) concentrations in normal adult men. Clinical Endocrinology 1995 42 673-676.
27. Olivecrona H, Johansson AG, Lindh E, Ljunghall S, Berglund L & Angelin B. Hormonal regulation of serum lipoprotein(a) levels. Contrasting effects of growth hormone and insulin-like growth factor-I. Arteriosclerosis, Thrombosis and Vascular Biology 1995 15 847-849.
28. Garry P, Collins P & Devlin JG. An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency. European Journal of Endocrinology 1996 134 61-66.
29. Hershkovitz E, Leiberman E, Limony Y, Shany Sh & Phillip M. Short-term growth hormone increases serum lipoprotein(a) levels in normal short children without growth hormone deficiency. Hormone Research 1996 46 38-40.
30. Laron Z & Butenandt O. Optimum use of growth hormone in children (Review). Drugs 1991 42 1-8.
31. Bengtsson BA, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. Journal of Clinical Endocrinology and Metabolism 1993 76 309-317.
32. Holloway L, Butterfield G, Hintz RL, Gesundheit N & Marcus R. Effects of recombinant human growth hormone on metabolic indices, body composition and bone turnover in healthy elderly women. Journal of Clinical Endocrinology and Metabolism 1994 79 470-479.
33. Holmes SJ & Shalet SM. Which adults develop side-effects of growth hormone replacement? Clinical Endocrinology 1995 43 143-149.